We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
PTC
PTC
$16.7B
| $5.72M | 0.02% |
31,100
-1,400
| -4% | -$265K |
|
427
SS&C Technologies
SSNC
$19.3B
| $5.63M | 0.02% |
74,345
+15,247
| +26% | +$1.14M |
|
428
Emcor
EME
$36.7B
| $5.54M | 0.02% |
12,216
-400
| -3% | -$189K |
|
429
W.R. Berkley
WRB
$26.2B
| $5.5M | 0.02% |
93,946
+38,474
| +69% | +$2.3M |
|
430
T. Rowe Price
TROW
$23.7B
| $5.37M | 0.02% |
47,448
-4,014
| -8% | -$465K |
|
431
Dow Inc
DOW
$21.9B
| $5.25M | 0.02% |
130,728
+2,037
| +2% | +$95K |
|
432
Hartford Financial Services
HIG
$37.8B
| $5.17M | 0.02% |
47,302
-36,013
| -43% | -$4.18M |
|
433
Liberty Media Series C
FWONK
$26B
| $5.17M | 0.02% |
55,800
+3,500
| +7% | +$297K |
|
|
P
434
Everpure Inc
P
$39B
| $5.13M | 0.02% |
83,553
-5,500
| -6% | -$306K |
|
435
United Airlines
UAL
$41B
| $5.13M | 0.02% |
52,866
+20,633
| +64% | +$1.74M |
|
436
Transmedics
TMDX
$3.11B
| $5.11M | 0.02% |
81,900
+17,500
| +27% | +$1.63M |
|
437
MakeMyTrip
MMYT
$5.71B
| $5.04M | 0.02% |
44,924
+3,800
| +9% | +$407K |
|
438
Markel Group
MKL
$22.8B
| $4.95M | 0.02% |
2,870
+368
| +15% | +$611K |
|
439
Insulet
PODD
$10.2B
| $4.94M | 0.02% |
18,916
+1,700
| +10% | +$428K |
|
440
Avantor
AVTR
$9.37B
| $4.88M | 0.02% |
231,468
-136,168
| -37% | -$3.06M |
|
441
Factset
FDS
$10.2B
| $4.83M | 0.02% |
10,051
-600
| -6% | -$285K |
|
442
Ford
F
$55.4B
| $4.83M | 0.02% |
487,493
-17,435
| -3% | -$186K |
|
443
NewAmsterdam Pharma
NAMS
$3.19B
| $4.82M | 0.02% |
+187,404
| New | +$3.98M |
|
444
Robinhood
HOOD
$89.3B
| $4.79M | 0.02% |
128,700
+3,100
| +2% | +$100K |
|
445
Johnson Controls International
JCI
$91.7B
| $4.75M | 0.02% |
60,124
+13,024
| +28% | +$1.04M |
|
446
Cardinal Health
CAH
$53.8B
| $4.71M | 0.02% |
39,783
+4,140
| +12% | +$483K |
|
447
Burlington
BURL
$22.4B
| $4.67M | 0.02% |
16,400
+400
| +3% | +$108K |
|
448
Masco
MAS
$14.7B
| $4.66M | 0.02% |
64,188
-10,035
| -14% | -$803K |
|
|
DOCU
449
DocuSign
DOCU
$12.2B
| $4.65M | 0.02% |
51,700
-1,500
| -3% | -$120K |
|
|
FITB
450
Fifth Third Bancorp
FITB
$52.5B
| $4.65M | 0.02% |
109,936
-14,157
| -11% | -$635K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.